Non-viable human embryos as a source of viable cells for embryonic stem cell derivation

被引:11
作者
Gavrilov, Svetlana [1 ]
Prosser, Robert W. [2 ]
Khalid, Imran [3 ]
MacDonald, Joanne [3 ]
Sauer, Mark V. [2 ]
Landry, Donald W. [3 ]
Papaioannou, Virginia E. [1 ]
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA
[3] Columbia Univ, Coll Phys & Surg, Dept Med, Div Expt Therapeut, New York, NY 10032 USA
关键词
ES cell derivation; hESC; human embryonic stem cells; non-viable human embryos; PREIMPLANTATION GENETIC DIAGNOSIS; CLEAVAGE-STAGE; MATERNAL AGE; BLASTOCYST; QUALITY; MORPHOLOGY; CULTURE; DEVELOP; INVITRO; FERTILIZATION;
D O I
10.1016/S1472-6483(10)60270-2
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Human embryonic stem cells (hESC) hold great promise for use in regenerative medicine. However, the extraordinary potential of hESC as therapeutic tools is tempered by ethical, moral and political issues surrounding their derivation from human embryos. It has previously been proposed that ethical criteria applied to essential organ donation could be employed for derivation of hESC from irreversibly arrested, and thus organismically dead, human embryos produced during routine IVF procedures. Here, it is shown that arrested embryos do not resume normal development during extended culture, yet most of them contain a substantial number of living cells on embryonic day 6 (72% have >1 viable cell, 47% have >5 viable cells), suggesting that this class of non-viable embryos could be a rich source of viable cells for derivation of hESC lines.
引用
收藏
页码:301 / 308
页数:8
相关论文
共 44 条
[1]   Cleavage anomalies in early human embryos and survival after prolonged culture in-vitro [J].
Alikani, M ;
Calderon, G ;
Tomkin, G ;
Garrisi, J ;
Kokot, M ;
Cohen, J .
HUMAN REPRODUCTION, 2000, 15 (12) :2634-2643
[2]   Nonviable human pre-implantation embryos as a source of stem cells for research and potential therapy [J].
Alikani, Mina ;
Munne, Santiago .
STEM CELL REVIEWS, 2005, 1 (04) :337-343
[3]  
Alikani Mina, 2002, Reprod Biomed Online, V5, P56
[4]   Human embryonic stem cells:: Current technologies and emerging industrial applications [J].
Ameen, Caroline ;
Strehl, Raimund ;
Bjorquist, Petter ;
Lindahl, Anders ;
Hyllner, Johan ;
Sartipy, Peter .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 65 (01) :54-80
[5]   DEVELOPMENT OF SPARE HUMAN PREIMPLANTATION EMBRYOS INVITRO - AN ANALYSIS OF THE CORRELATIONS AMONG GROSS MORPHOLOGY, CLEAVAGE RATES, AND DEVELOPMENT TO THE BLASTOCYST [J].
BOLTON, VN ;
HAWES, SM ;
TAYLOR, CT ;
PARSONS, JH .
JOURNAL OF IN VITRO FERTILIZATION AND EMBRYO TRANSFER, 1989, 6 (01) :30-35
[6]  
Bongso A, 2006, METH MOL B, V331, P13
[7]  
*CDCP, 2005, ASS REPR TECHN ART R
[8]   Can human embryonic stem cells contribute to the discovery of safer and more effective drugs? [J].
Cezar, Gabriela Gebrin .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2007, 11 (04) :405-409
[9]   Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres [J].
Chung, Y ;
Klimanskaya, I ;
Becker, S ;
Marh, J ;
Lu, SJ ;
Johnson, J ;
Meisner, L ;
Lanza, R .
NATURE, 2006, 439 (7073) :216-219
[10]   Human embryonic stem cell lines generated without embryo destruction [J].
Chung, Young ;
Klimanskaya, Irina ;
Becker, Sandy ;
Li, Tong ;
Maserati, Marc ;
Lu, Shi-Jiang ;
Zdravkovic, Tamara ;
Ilic, Dusko ;
Genbacev, Olga ;
Fisher, Susan ;
Krtolica, Ana ;
Lanza, Robert .
CELL STEM CELL, 2008, 2 (02) :113-117